De Paschale Massimo, Cagnin Debora, Cerulli Teresa, Manco Maria Teresa, Agrappi Carlo, Mirri Paola, Gatti Arianna, Rescaldani Cristina, Clerici Pierangelo
Microbiology Unit, Hospital of Legnano, Via Candiani 2, 20025 Legnano MI, Italy.
Int J Microbiol. 2010;2010:695104. doi: 10.1155/2010/695104. Epub 2010 Jun 20.
The presence of an "isolated viral capsid antigen (VCA) IgG" pattern in serum is not easy to interpret without the aid of further tests, such as specific immunoblotting or a virus genome search, that often give rise to organisational and economic problems. However, one alternative is to use an enzyme-linked immunosorbent assay (ELISA) to detect anti-early antigen (EA) antibodies, which can be found in about 85% of subjects with acute Epstein-Barr virus (EBV) infections. The purpose of this work was to search for anti-EA(D) antibodies in 130 samples with an isolated VCA IgG pattern at ELISA screening and classified as being indicative of past (102 cases) or acute (28 cases) infection on the basis of the immunoblotting results. Thirty-seven samples (28.5%) were positive for anti-EA(D), of which 25 (89.3%) had been classified by immunoblotting as indicating acute and 12 (11.8%) past EBV infection. This difference was statistically significant (P < .01). The results of our search for anti-EA(D) antibodies correctly identified nearly 90% of acute (presence) or past EBV infections (absence). When other tests are not available, the search for anti-EA antibodies may therefore be helpful in diagnosing patients with an isolated VCA IgG pattern at screening tests.
血清中出现“孤立的病毒衣壳抗原(VCA)IgG”模式,如果没有进一步检测(如特异性免疫印迹或病毒基因组搜索)的辅助,很难进行解读,而这些检测往往会带来组织和经济方面的问题。然而,一种替代方法是使用酶联免疫吸附测定(ELISA)来检测抗早期抗原(EA)抗体,在约85%的急性爱泼斯坦-巴尔病毒(EBV)感染患者中可以检测到这种抗体。这项研究的目的是在ELISA筛查中对130份具有孤立VCA IgG模式的样本进行抗EA(D)抗体检测,并根据免疫印迹结果将其分类为既往感染(102例)或急性感染(28例)。37份样本(28.5%)抗EA(D)呈阳性,其中25份(89.3%)经免疫印迹分类为急性EBV感染,12份(11.8%)为既往EBV感染。这种差异具有统计学意义(P <.01)。我们对抗EA(D)抗体的检测结果正确识别了近90%的急性(存在)或既往EBV感染(不存在)。因此,当无法进行其他检测时,检测抗EA抗体可能有助于诊断筛查试验中具有孤立VCA IgG模式的患者。